Last reviewed · How we verify
NCT03742843
A Multi-omics Study of Adenomyosis
trial testing A multi-omics analysis in Adenomyosis in 200 participants. Status unknown.
23 November 2020
Quick facts
| Lead sponsor | Lei Li |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 10 November 2018 |
| Primary completion | 23 November 2020 |
| Estimated completion | 23 November 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- A multi-omics analysis
Conditions studied
- Adenomyosis — all drugs for Adenomyosis →
- Endometriosis — all drugs for Endometriosis →
- Ectopic Endometrium — all drugs for Ectopic Endometrium →
- Eutopic Endometrium — all drugs for Eutopic Endometrium →
Sponsor
Lei Li — full company profile →
Who can join
18 and older, female only, with Adenomyosis or Endometriosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to analyze the multi-omics results between eutopic endometrium, adenomyosis and endometriosis of patients diagnosed of adenomyosis with and without endometriosis. The multi-omics profiles include whole exome sequencing, analysis of transcriptomics and metabolomics. A comprehensive multi-omics will reveal the pathogenesis of adenomyosis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Whole genome doubling in adenomyosis.
Chao X, Chen X, Su H, Shang X, et al · · 2024 · cited 1× · PMID 39129207 · DOI 10.1002/ctm2.1809
Verify or expand the search:
- PubMed search for NCT03742843
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of A multi-omics analysis
Trials testing the same drug.
- NCT03742856 — A Multi-omics Study of Epithelial Ovarian Cancer · unknown
- NCT03742869 — HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma · unknown
Other recruiting trials for Adenomyosis
Currently open trials in the same condition.
- NCT07455721 — Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Therapeutic Failure · active not recruiting
- NCT07486622 — Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical St · active not recruiting
- NCT06572852 — Next-Generation Endometriosis Diagnostics Through Comprehensive Multi-Dimensional Analysis · recruiting
- NCT06364592 — Electroacupuncture for Dysmenorrhea Secondary to Adenomyosis · NA · recruiting
- NCT06604091 — Cohort Profile：The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart) · active not recruiting
Other Lei Li trials
Trials by the same sponsor.
- NCT06558019 — Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence · not yet recruiting
- NCT06557954 — Cervical Cytology DNA Methylation for Cervical Cancer Screening · not yet recruiting
- NCT05801263 — ctDNA Methylation for Epithelial Ovarian Cancer · unknown
- NCT05801276 — ctDNA Methylation for Detecting Ovarian Cancer · unknown
- NCT06490380 — HRD Status Reference Standard Based on WGS · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03742843 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lei Li
- Last refreshed: 15 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03742843.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing